Pharmacological characterization of the antidiabetic drug metformin in atherosclerosis inhibition: A comprehensive insight

Abstract Background Atherosclerosis (AS) is a progressive disease that interferes with blood flow, leading to cardiovascular complications such as hypertension, ischemic heart disease, ischemic stroke, and vascular ischemia. The progression of AS is correlated with inflammation, oxidative stress, an...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Areej Turkistani, Haydar M. Al‐Kuraishy, Ali I. Al‐Gareeb, Athanasios Alexiou, Marios Papadakis, Mostafa M. Bahaa, Salah Al‐Windy, Gaber El‐Saber Batiha
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2024-08-01
Reeks:	Immunity, Inflammation and Disease
Onderwerpen:	atherosclerosis Kruppel like factor 2 metformin nuclear erythroid related factor 2
Online toegang:	https://doi.org/10.1002/iid3.1346
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!